Veracyte VCYT Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veracyte's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veracyte's common stock, shares authorized (in shares)?
- Veracyte (VCYT) reported common stock, shares authorized (in shares) of $125M in Q1 2026.
- How has Veracyte's common stock, shares authorized (in shares) changed year-over-year?
- Veracyte's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $125M to $125M.
- What is the long-term trend for Veracyte's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Veracyte's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $125M to $125M.